AHR antagonist 5 hemimaleate
AHR antagonist 5 hemimaleate is a potent, orally bioavailable aryl hydrocarbon receptor (AHR) inhibitor with an IC50 below 0.5 μM. It demonstrates synergistic antitumor activity in combination with anti-PD-1 therapy in preclinical models, making it a valuable tool for immuno-oncology and cancer metabolism research.
Product Specifications
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Formula
C29H28FN7O4
Molecular Weight
499.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
